Anal cancer and rectal cancer are sometimes confused because they affect neighboring parts of the body. However, they are distinct diseases with different causes, risk factors, symptoms and treatments.
Anal cancer occurs in the anal canal, the short passage between the rectum and the outside of the body. Human papillomavirus (HPV) infection is attributed to some 90% of these cancers .
Rectal cancer develops in the rectum, the final section of the large intestine before the anus. It is a type of colorectal (bowel) cancer and is typically associated with genetic mutations and long-term conditions like inflammatory bowel disease (IBD).
Understanding the differences between anal vs rectal cancer can help patients and caregivers navigate diagnosis, treatment, and support options.
Symptoms of Rectal Cancer
The symptoms of rectal cancer can be subtle at first, often overlapping with other digestive conditions. Common symptoms include:
- Blood in the stool or rectal bleeding.
- Persistent changes in bowel habits (diarrhea, constipation, or narrowing of stools).
- A feeling of incomplete bowel emptying.
- Abdominal pain or cramping.
- Unexplained weight loss.
- Fatigue or weakness.
If you experience these symptoms for more than a few weeks, speak with a healthcare professional to rule out serious conditions, including rectal cancer.
Symptoms of Anal Cancer
Anal cancer symptoms may also be mistaken for hemorrhoids or other problems that are not life-threatening, leading to delays in diagnosis. Common symptoms include:
- Rectal bleeding, often mistaken for hemorrhoids.
- Pain or pressure in the anal area.
- Unusual anal discharge or mucus.
- A lump or mass near the anus.
- Itching or irritation in the anal region.
- Changes in bowel habits, including narrowing of stools.
Early detection is key to improving outcomes, so it is important to seek medical advice if any of these anal or rectal cancer symptoms are persistent.
Risk Factors for Rectal Cancer
Rectal cancer is influenced by genetic, environmental and lifestyle factors. Key risk factors include:
- Age: Most cases occur in people over 50.
- Family history: A history of colorectal cancer in close relatives increases risk.
- Diet: A diet high in red and processed meats may contribute.
- Inflammatory bowel disease (IBD): Conditions like ulcerative colitis and Crohn’s disease elevate risk.
- Lifestyle factors: Smoking, obesity and alcohol consumption may contribute.
- Genetic syndromes: Conditions like Lynch syndrome increase susceptibility.
Risk Factors for Anal Cancer
Anal cancer is often linked to HPV infection, but other factors may also play a role. Common risk factors include:
- HPV infection: A major cause of anal cancer, especially high-risk HPV strains.
- Smoking: Tobacco use weakens the immune system and increases risk.
- Weakened immune system: Conditions like HIV/AIDS raise the likelihood of developing anal cancer.
- History of cervical, vaginal, or vulvar cancer: These cancers share common risk factors with anal cancer.
- Anal intercourse: May slightly increase risk due to HPV transmission.
- Chronic inflammation: Conditions like anal fissures or fistulas may contribute.
Understanding these risk factors can help with prevention and early detection of rectal vs anal cancer.
How Anal Cancer is Treated vs How Rectal Cancer is Treated
Treatment approaches for anal vs rectal cancer differ due to their unique characteristics.
Anal Cancer Treatment
The treatment for anal cancer is dependent on the size of the tumor, its stage and type. Treatment options for anal cancer include:
- Chemotherapy: usually involving the drugs mitomycin-C and 5-fluorouracil (5-FU).
- Radiation: directed towards the cancer location to shrink tumors and kill anal cancer cells.
- Surgery: although uncommon this can be used for early-stage anal cancer when the tumor is extremely small and localized.
For stages I – III, the standard protocol is radiation and chemotherapy, used in conjunction with one another (often called 'chemoradiation'). This is known collectively as the Nigro Protocol.
Learn more about anal cancer treatment.
Rectal Cancer Treatment
Treatment for rectal cancer typically involves surgery, often followed by chemotherapy and/or radiation therapy. Early-stage rectal cancer may be treated with local excision, while advanced cases may require a more extensive procedure such as a low anterior resection (LAR) or abdominoperineal resection (APR).
Targeted therapies and immunotherapy are also being explored for both cancers in clinical trials.
Resources for Rectal Cancer Patients
If you or a loved one has been diagnosed with rectal cancer, support is available through various organizations. Resources include:
- Colorectal Cancer Alliance – what are the differences between colon and rectal cancer
- American Cancer Society – what is colorectal cancer
- Macmillan Cancer Support – Rectal Cancer
- Bowel Cancer UK – Ask the Nurse
How We Help Anal Cancer Patients
We aim to provide anal cancer thrivers (our word for patients) with comprehensive resources and information. Learn more about anal cancer prevention, screening and anal precancer, treatment, and managing the side effects of treatment.
We also work to support thrivers and caregivers with our unique peer-to-peer support program. This pairs thrivers and caregivers with trained volunteers who have experienced anal cancer treatment and recovery. Register for the thrivers P2P program or the caregivers P2P program.
Anal cancer and rectal cancer are sometimes confused because they affect neighbouring parts of the body. However, they are distinct diseases with different causes, risk factors, symptoms and treatments.
Anal cancer occurs in the anal canal, the short passage between the rectum and the outside of the body. Human papillomavirus (HPV) infection is linked to around 90% of these cancers.
Rectal cancer develops in the rectum, the final section of the large intestine before the anus. It is a type of bowel cancer and is typically associated with genetic mutations and long-term conditions such as inflammatory bowel disease (IBD).
Understanding the differences between anal and rectal cancer can help patients and carers navigate diagnosis, treatment and support options.
Symptoms of Rectal Cancer
The symptoms of rectal cancer can be subtle at first, often overlapping with other digestive conditions. Common symptoms include:
- Blood in the stools or rectal bleeding.
- Persistent changes in bowel habits (diarrhoea, constipation, or narrowing of stools).
- A feeling of incomplete bowel emptying.
- Abdominal pain or cramping.
- Unexplained weight loss.
- Fatigue or weakness.
If you experience these symptoms for more than a few weeks, speak to your GP or another healthcare professional to rule out serious conditions, including rectal cancer.
Symptoms of Anal Cancer
Anal cancer symptoms may also be mistaken for haemorrhoids or other non-serious conditions, leading to delays in diagnosis. Common symptoms include:
- Rectal bleeding, often mistaken for haemorrhoids.
- Pain or pressure in the anal area.
- Unusual anal discharge or mucus.
- A lump or mass near the anus.
- Itching or irritation in the anal area.
- Changes in bowel habits, including narrowing of stools.
Early detection is key to improving outcomes, so it is important to seek medical advice if any of these anal or rectal cancer symptoms persist.
Risk Factors for Rectal Cancer
Rectal cancer is influenced by genetic, environmental and lifestyle factors. Key risk factors include:
- Age: Most cases occur in people over 50.
- Family history: A history of bowel cancer in close relatives increases risk.
- Diet: A diet high in red and processed meats may contribute.
- Inflammatory bowel disease (IBD): Conditions such as ulcerative colitis and Crohn’s disease increase risk.
- Lifestyle factors: Smoking, obesity and alcohol consumption may contribute.
- Genetic syndromes: Conditions such as Lynch syndrome increase susceptibility.
Risk Factors for Anal Cancer
Anal cancer is often linked to HPV infection, but other factors may also play a role. Common risk factors include:
- HPV infection: A major cause of anal cancer, especially high-risk HPV strains.
- Smoking: Tobacco use weakens the immune system and increases risk.
- Weakened immune system: Conditions such as HIV increase the likelihood of developing anal cancer.
- History of cervical, vaginal or vulval cancer: These cancers share common risk factors with anal cancer.
- Anal intercourse: May slightly increase risk because of HPV transmission.
- Chronic inflammation: Conditions such as anal fissures or fistulas may contribute.
Understanding these risk factors can help with prevention and early detection of rectal and anal cancer.
How Anal Cancer is Treated Compared With Rectal Cancer
Treatment approaches for anal and rectal cancer differ because of their distinct characteristics.
Anal Cancer Treatment
Treatment for anal cancer depends on the size of the tumour, its stage and type.
Treatment options for anal cancer include:
- Chemotherapy, usually involving the drugs mitomycin-C and either 5-fluorouracil (5-FU) or capecitabine.
- Radiotherapy, directed at the cancer to shrink tumours and kill cancer cells.
- Surgery, although uncommon, may be used for early-stage anal cancer when the tumour is extremely small and localised.
For stages 1 to 3, the standard treatment is radiotherapy together with chemotherapy, often called chemoradiotherapy. This approach is sometimes referred to as the Nigro protocol.
Learn more about anal cancer treatment.
Rectal Cancer Treatment
Treatment for rectal cancer typically involves surgery, often followed by chemotherapy and/or radiotherapy. Early-stage rectal cancer may be treated with local excision, while advanced cases may require a more extensive procedure such as a low anterior resection (LAR) or abdominoperineal resection (APR).
Targeted therapies and immunotherapy are also being explored for both cancers in clinical trials.
Resources for Rectal Cancer Patients
If you or a loved one has been diagnosed with rectal cancer, support is available through various organisations. Resources include:
How We Help Anal Cancer Patients
We aim to provide anal cancer patients (thrivers) with comprehensive resources and information. Learn more about anal cancer prevention, screening and anal precancer, treatment and managing the side effects of treatment.
We also work to support patients (thrivers) and carers through our unique peer-to-peer support programme. This pairs patients and carers with trained volunteers who have experienced anal cancer treatment and recovery. Register for the thrivers P2P programme or the caregivers P2P programme.
Share this: on Twitter on Facebook
